title: Careful use of science to advance the debate on the UK Cancer Drugs Fund.
authors.affiliation: Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
authors.forename: Darius N
authors.initials: DN
authors.lastname: Lakdawalla
authors.affiliation: Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts3Massachusetts General Hospital, Boston4National Bureau of Economic Research, Cambridge, Massachusetts.
authors.forename: Anupam B
authors.initials: AB
authors.lastname: Jena
authors.affiliation: Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
authors.forename: Jason N
authors.initials: JN
authors.lastname: Doctor
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics; D019317:Evidence-Based Medicine; D005380:Financing, Government; D006291:Health Policy; D006801:Humans; D019458:Insurance Coverage; D057240:Patient Preference; D016032:Randomized Controlled Trials as Topic; D013222:State Medicine / Q000191:economics*; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents